Edition:
United Kingdom

Sanofi India Ltd (SANO.NS)

SANO.NS on National Stock Exchange of India

6,099.40INR
9:59am GMT
Change (% chg)

Rs13.00 (+0.21%)
Prev Close
Rs6,086.40
Open
Rs6,075.00
Day's High
Rs6,170.00
Day's Low
Rs6,050.25
Volume
10,864
Avg. Vol
14,048
52-wk High
Rs6,774.95
52-wk Low
Rs4,276.00

Summary

Name Age Since Current Position

Aditya Narayan

2016 Independent Non-Executive Chairman of the Board

Charles Billard

2018 Chief Financial Officer, Whole time Director

Girish Tekchandani

2016 Compliance Officer, Company Secretary

Rajaram Narayanan

49 2018 Managing Director, Whole Time Director

A. Sood

2017 Whole Time Director

Cyril Grandchamp-Desraux

2017 Additional Director

Thomas Rouckout

2017 Additional Director

Shailesh Ayyangar

61 2017 Non-Executive Director

F. Briens

55 2011 Non-Executive Director

Rangaswamy Iyer

62 2016 Independent Director

Biographies

Name Description

Aditya Narayan

Charles Billard

Mr. Charles Billard ha been appointed as Chief Financial Officer, Whole time Director of the Company. Mr. Charles Billard has 13 years' of experience in business analysis, controlling, strategy and business development. He joined Sanofi in February 2014 as Vice President Strategy and Business Development responsible for Global Consumer Healthcare Division Strategy and Business Development. In August 2016 he took up the role of Regional Head of Business Analysis & Controlling for the General Medicine and Emerging Markets at Sanofi Group. Prior to joining Sanofi he was working with Boston Consulting Group since June 2005 in various roles of increasing responsibility. He was core member of BCG Healthcare and Industrial Goods practices. He has completed Ecole Centrale Paris (ECP) after "class.

Girish Tekchandani

Rajaram Narayanan

A. Sood

Cyril Grandchamp-Desraux

Thomas Rouckout

Shailesh Ayyangar

Dr. Shailesh Ayyangar is re-designated as Non-Executive Director of the Company effective December 31st, 2017. He is currently serves as Managing Director, Executive Director of Sanofi India Limited. He served as the Wholetime Director of Sanofi- Synthelabo (India) Limited. His qualifications are B.V.Fc & A.H., P.G.D.M. IIM (Ahmedabad). Dr. Shailesh Ayyangar assumed office as Managing Director of Aventis Pharma Limited on October 25, 2005. Dr. Ayyangar has wide-ranging experience in the pharmaceutical industry. He held senior Sales and Marketing positions in SmithKline Beecham Pharmaceuticals and GlaxoSmithKline (GSK) in India and Great Britain. He was also Wholetime Director of SmithKline Beecham Pharmaceuticals before its merger with GlaxoWellcome. He was Head of the Tropical Medicine Business unit for International Markets in SmithKline Beecham, UK, for four years prior to his return to India. A graduate in Veterinary Science, Dr. Ayyangar holds a Post-graduate Degree in Business Management from the Indian Institute of Management (IIM), Ahmedabad, Gujarat.

F. Briens

Mr. F. Briens is the Non-Executive Director of the company. Mr. Briens joined in the Sanofi Group in March 1988 as an Internal Auditor. Since then, he served in a variety of positions including Director of Controlling in the USA and CFO Interlatina Zone in Panama. After the merger with Synthelabo, he was nominated Deputy Director in the Audit department and then CFO for the Latin America Region. In January 2000, he was appointed to his current position as Vice-President, Chief Financial Officer for the Intercontinental Region of Sanofi.

Rangaswamy Iyer

Mr. Rangaswamy R. Iyer is an Independent Director of the Company. He was MD of Wyeth Limited for about ten years till end October 2009.